Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial.

Add item related to this paper

  • MiniManuscript ID
    62073
  • Pubmed ID
    21835220